7 stories found
ImageneBio, Neurogene, and Compugen have announced their participation in the H.C. Wainwright 28th Annual Global Investment Conference. The event will provide these biotechnology companies with a platform to present their strategies to institutional investors.
A 50-year-old mother was sentenced to one year in prison in Marseille for administering cocaine to her 10-year-old daughter, who was hospitalized with a neurogenetic disease.
Neurogene announced its GAAP EPS at -$4.24, which surpassed analyst expectations by $0.04. The company's financial results indicate a slight beat on earnings per share.
A group of publicly traded biotechnology and pharmaceutical companies, including ORIC Pharmaceuticals, Intellia Therapeutics, and Insmed, have announced new employee inducement grants. These compensation packages were structured to comply with Nasdaq Listing Rule 5635(c)(4).
A neurogeneticist explains the importance of the brain's nightly 'cleanup' process and offers practical tips for improving sleep hygiene. Recommendations include writing lists before bed and proper preparation for sleep to avoid serious health problems.
Neurogene has launched a public stock offering, a move that typically aims to raise capital for the company's operations and future growth.
An international expert in adult neurogenesis and CSIC researcher, Trejo, highlights how current exercise habits could positively influence the brain development of future children and grandchildren. His work focuses on the impact of exercise on brain health.